Marso S.P., Daniels G.H., Brown-Frandsen K., et al
This new study adds to a growing body of evidence that GLP-1 medicines may play a role in lowering dementia risk. After applying matching methods to control for confounding factors, the study included over 174,000 patients, evenly divided between the two treatment groups
Read more about what policymakers can do stop brand drug manufacturers from using anticompetitive tactics to block generic competition
It may occur in more open lowlands and grasslands in tropical regions
S., Liu, R., Zhao, Y., & ACHIEVE-3 Investigators (2026)